The Evolution Of Glaucoma Treatment : Comparative Outlook On Minimally Invasive Glaucoma Surgery Devices With Conventional Procedures
Table of Contents
Chapter 1. The Evolution of Glaucoma Treatment: Comparative Outlook on Minimally Invasive Glaucoma Surgery Devices (MIGS) with Conventional Procedures
1.1. Overview of the Glaucoma Surgery Industry
1.2. Conventional Glaucoma Surgeries and MIGS Devices
1.2.1. Traditional Glaucoma Surgeries
1.2.1.1. Trabeculectomy
1.2.1.1.1. Procedures Performed from 2021 to 2030-
1.2.1.1.1.1. North America
1.2.1.1.1.2. Europe
1.2.1.1.1.3. Asia-Pacific
1.2.1.1.1.4. Latin America
1.2.1.1.1.5. Middle East & Africa
1.2.1.2. Transscleral Cyclophotocoagulation (TSCPC) and Endoscopic Cyclophotocoagulation (ECP)
1.2.1.2.1. Procedures Performed from 2021 to 2030-
1.2.1.2.1.1. North America
1.2.1.2.1.2. Europe Asia-Pacific
1.2.1.2.1.3. Latin America
1.2.1.2.1.4. Middle East & Africa
1.2.2. MIGS Devices
1.2.2.1. iStent Implants
1.2.2.1.1. Product Volume (in Mn Units) from 2021 to 2030-
1.2.2.1.1.1. North America
1.2.2.1.1.2. Europe
1.2.2.1.1.3. Asia-Pacific
1.2.2.1.1.4. Latin America
1.2.2.1.1.5. Middle East & Africa
1.2.2.2. Hydrus Implants
1.2.2.2.1. Product Volume (in Mn Units) from 2021 to 2030-
1.2.2.2.1.1. North America
1.2.2.2.1.2. Europe
1.2.2.2.1.3. Asia-Pacific
1.2.2.2.1.4. Latin America
1.2.2.2.1.5. Middle East & Africa
1.2.2.3. Microshunt PRESERFLO
1.2.2.4. Ex-PRESS
1.2.2.4.1. Product Volume (in Mn Units) from 2021 to 2030-
1.2.2.4.1.1. North America
1.2.2.4.1.2. Europe
1.2.2.4.1.3. Asia-Pacific
1.2.2.4.1.4. Latin America
1.2.2.4.1.5. Middle East & Africa
1.2.2.5. XEN Implants
1.2.2.5.1. Product Volume (in Mn Units) from 2021 to 2030-
1.2.2.5.1.1. North America
1.2.2.5.1.2. Europe
1.2.2.5.1.3. Asia-Pacific
1.2.2.5.1.4. Latin America
1.2.2.5.1.5. Middle East & Africa
1.2.2.6. Ahmed Valve
1.2.2.6.1. Product Volume (in Mn Units) from 2021 to 2030-
1.2.2.6.1.1. North America
1.2.2.6.1.2. Europe
1.2.2.6.1.3. Asia-Pacific
1.2.2.6.1.4. Latin America
1.2.2.6.1.5. Middle East & Africa
1.2.2.7. Baerveldt
1.2.2.7.1. Product Volume (in Mn Units) from 2021 to 2030-
1.2.2.7.1.1. North America
1.2.2.7.1.2. Europe
1.2.2.7.1.3. Asia-Pacific
1.2.2.7.1.4. Latin America
1.2.2.7.1.5. Middle East & Africa
1.3. Emergence and Mechanism of MIGS Devices
1.3.1. iStent Implants
1.3.2. Hydrus Implants
1.3.3. Microshunt PRESERFLO
1.3.4. Xen Implant, Ex-PRESS, Ahmed Valve, and Baerveldt
1.4. Steady Growth of Traditional Glaucoma Surgeries Across Certain Regions
1.5. Comparative Analysis Between Traditional Glaucoma Surgeries and MIGS Devices
ISO 9001:2015 & 27001:2022 Certified
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.
Trusted market insights - try a free sample
See how our reports are structured and why industry leaders rely on Grand View Research. Get a free sample or ask us to tailor this report to your needs.
